Selegiline

Generic name: Pronounced as (se le' ji leen)
Brand names
  • Eldepryl®
  • Zelapar®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 01/15/2022

Selegiline is used to help control the symptoms of Parkinson's disease (PD; a disorder of the nervous system that causes difficulties with movement, muscle control, and balance) in people who are taking levodopa and carbidopa combination (Sinemet). Selegiline may help people with Parkinson's disease by decreasing the dose of levodopa/carbidopa needed to control symptoms, stopping the effects of levodopa/carbidopa from wearing off between doses, and increasing the length of time that levodopa/carbidopa will continue to control symptoms. Selegiline is in a group of medications called monoamine oxidase type B (MAO-B) inhibitors. It works by increasing the amount of dopamine (a natural substance that is needed to control movement) in the brain.

Selegiline comes as a capsule and an orally disintegrating (dissolving) tablet to take by mouth. The capsule is usually taken twice a day with breakfast and with lunch. The orally disintegrating tablet is usually taken once a day before breakfast without food, water, or other liquids. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take selegiline exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor. If you take too much selegiline, you may experience a sudden and dangerous increase in your blood pressure.

If you are taking the orally disintegrating tablet, do not remove the blister that contains the tablets from the outer pouch until you are ready to take a dose. When it is time for your dose, remove the blister card from the outer pouch and use dry hands to peel open one blister. Do not try to push the tablet through the foil. Place the tablet on your tongue and wait for it to dissolve. Do not swallow the tablet. Do not eat or drink anything for 5 minutes before you take the tablet and for 5 minutes after you take the tablet.

If you are taking the orally disintegrating tablet, your doctor may start you on a low dose of selegiline and increase your dose after six weeks.

Tell your doctor if you experience nausea, stomach pain, or dizziness. Your doctor may decrease your dose of levodopa/carbidopa during your treatment with selegiline, especially if you experience these symptoms or other unusual symptoms. Follow these directions carefully and ask your doctor or pharmacist if you do not know how much medication you should take. Do not change the doses of any of your medications unless your doctor tells you that you should.

Selegiline may help to control the symptoms of PD, but it will not cure the condition. Do not stop taking selegiline without talking with your doctor. If you suddenly stop taking medications for Parkinson's disease such as selegiline, you may experience fever, sweating, stiff muscles, and loss of consciousness. Call your doctor if you experience these or other unusual symptoms after you stop taking selegiline.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking selegiline,

  • tell your doctor and pharmacist if you are allergic to selegiline, or any other medications.

  • tell your doctor if you are taking, have recently taken, or plan to take any of the following prescription and nonprescription medications: dextromethorphan (Robitussin); meperidine (Demerol); methadone (Dolophine), propoxyphene (Darvon); tramadol (Ultram, in Ultracet); and other medications that contain selegiline (Eldepryl, Emsam, Zelapar). Your doctor may tell you not to take selegiline if you are taking or have recently taken any of these medications. If you stop taking selegiline, your doctor may tell you not to take these medications until at least 14 days have passed since you last took selegiline.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking. Be sure to mention any of the following: antidepressants such as amitriptyline (Elavil) and imipramine (Tofranil); carbamazepine (Carbatrol, Equetro); medications for cough and cold symptoms or for weight loss; nafcillin; phenobarbital; phenytoin (Dilantin); selective serotonin reuptake inhibitors such as citalopram (Celexa), escitalopram (Lexapro), fluoxetine (Prozac), fluvoxamine (Luvox), paroxetine (Paxil), and sertraline (Zoloft); and rifampin (Rifadin, Rimactane). Your doctor may need to change the doses of your medications or monitor you more carefully for side effects.

  • tell your doctor if you have or have ever had liver or kidney disease.

  • if you have phenylketonuria (PKU; an inherited condition in which a special diet must be followed to prevent damage to your brain that can cause severe intellectual disability), you should know that the orally disintegrating tablets contain phenylalanine.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking selegiline, call your doctor.

  • you should know that selegiline may cause dizziness, lightheadedness, and fainting when you get up too quickly from a lying position. This is more common when you first start taking selegiline. To avoid this problem, get out of bed slowly, resting your feet on the floor for a few minutes before standing up.

Ask your doctor if you need to avoid any foods during your treatment with selegiline. Your doctor will probably tell you that you may continue your normal diet as long as you take selegiline exactly as directed.

Take the missed dose as soon as you remember it. However, if it is almost time for your next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Selegiline may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • dizziness

    • lightheadedness

    • fainting

    • dry mouth

    • nausea

    • vomiting

    • stomach pain

    • difficulty swallowing

    • heartburn

    • diarrhea

    • gas

    • constipation

    • difficulty falling asleep or staying asleep

    • unusual dreams

    • sleepiness

    • depression

    • pain, especially in the legs or back

    • muscle pain or weakness

    • purple blotches on the skin

    • rash

    • redness, irritation, or sores in the mouth (if you are taking the orally disintegrating tablets)

  • Some side effects can be serious. If you experience any of the following symptoms, call your doctor immediately:

    • severe headache

    • chest pain

    • fast, irregular, or pounding heartbeat

    • sweating

    • sudden, severe nausea and vomiting

    • confusion

    • stiff or sore neck

    • uncontrollable shaking of a part of your body

    • unusual movements that are difficult to control

    • hallucinations (seeing thing or hearing voices that do not exist)

    • difficulty breathing

  • People who have PD may have an increased risk of developing melanoma (a type of skin cancer). There is not enough information to tell whether selegiline or other medications for PD increase the risk of melanoma. Talk to your doctor about the risks of taking selegiline and about whether you should have your skin examined during your treatment.

  • Selegiline may cause other side effects. Call your doctor if you have any unusual problems while you are taking this medication.

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Dispose of any unused orally disintegrating tablets three months after you open the protective pouch.

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include:

  • drowsiness

  • dizziness

  • faintness

  • irritability

  • hyperactivity

  • agitation

  • severe headache

  • hallucinations (seeing things or hearing voices that do not exist)

  • jaw tightness

  • stiffness and arching of the back

  • seizures

  • coma (loss of consciousness for a period of time)

  • fast and irregular pulse

  • chest pain

  • slowed breathing

  • sweating

  • fever

  • cold, clammy skin

Keep all appointments with your doctor.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The metabolism of Selegiline can be decreased when combined with Moxifloxacin.
Repaglinide Repaglinide The metabolism of Selegiline can be decreased when combined with Repaglinide.
Montelukast Montelukast The metabolism of Selegiline can be decreased when combined with Montelukast.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The metabolism of Selegiline can be increased when combined with Insulin glargine.
Leflunomide Leflunomide The serum concentration of Selegiline can be decreased when it is combined with Leflunomide.
Delavirdine Delavirdine The metabolism of Selegiline can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Selegiline can be increased when combined with Nevirapine.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Selegiline.
Dolasetron Dolasetron The risk or severity of adverse effects can be increased when Dolasetron is combined with Selegiline.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Selegiline.
Anagrelide Anagrelide The metabolism of Anagrelide can be decreased when combined with Selegiline.
Candesartan Candesartan Selegiline may increase the hypotensive activities of Candesartan.
Cilostazol Cilostazol The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Cilostazol.
Clopidogrel Clopidogrel The metabolism of Selegiline can be decreased when combined with Clopidogrel.
Diphenoxylate Diphenoxylate The risk or severity of adverse effects can be increased when Selegiline is combined with Diphenoxylate.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The metabolism of Selegiline can be decreased when combined with Conjugated estrogens.
Fenofibrate Fenofibrate The metabolism of Selegiline can be decreased when combined with Fenofibrate.
Guanfacine Guanfacine Selegiline may increase the hypotensive activities of Guanfacine.
Methylergonovine Methylergonovine The risk or severity of hypertension can be increased when Methylergometrine is combined with Selegiline.
Miglitol Miglitol Selegiline may increase the hypoglycemic activities of Miglitol.
Naratriptan Naratriptan The metabolism of Naratriptan can be decreased when combined with Selegiline.
Olsalazine Olsalazine The risk or severity of hypertension can be increased when Selegiline is combined with Olsalazine.
Paregoric Paregoric Selegiline may increase the analgesic activities of Morphine.
Penbutolol Penbutolol Selegiline may increase the hypotensive activities of Acebutolol.
Pentazocine Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Selegiline.
Prednisone Prednisone The metabolism of Selegiline can be increased when combined with Prednisone.
Ranitidine Ranitidine The metabolism of Ranitidine can be decreased when combined with Selegiline.
Reserpine Reserpine The risk or severity of adverse effects can be increased when Selegiline is combined with Reserpine.
Rizatriptan Rizatriptan The metabolism of Rizatriptan can be decreased when combined with Selegiline.
Sumatriptan Sumatriptan The metabolism of Sumatriptan can be decreased when combined with Selegiline.
Tizanidine Tizanidine The metabolism of Tizanidine can be decreased when combined with Selegiline.
Zolmitriptan Zolmitriptan The metabolism of Zolmitriptan can be decreased when combined with Selegiline.
Famotidine Injection Famotidine Injection The metabolism of Selegiline can be decreased when combined with Famotidine.
Fluconazole Injection Fluconazole Injection The metabolism of Selegiline can be decreased when combined with Fluconazole.
Hydromorphone Injection Hydromorphone Injection Selegiline may increase the serotonergic activities of Hydromorphone.
Interferon Beta-1b Injection Interferon Beta-1b Injection The metabolism of Selegiline can be decreased when combined with Interferon beta-1b.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The metabolism of Selegiline can be decreased when combined with Interferon gamma-1b.
Levofloxacin Injection Levofloxacin Injection The metabolism of Selegiline can be decreased when combined with Levofloxacin.
Meperidine Injection Meperidine Injection The risk or severity of serotonin syndrome and opioid toxicity can be increased when Selegiline is combined with Meperidine.
Metoclopramide Injection Metoclopramide Injection The risk or severity of sedation can be increased when Metoclopramide is combined with Selegiline.
Metronidazole Injection Metronidazole Injection The metabolism of Selegiline can be decreased when combined with Metronidazole.
Morphine Injection Morphine Injection Selegiline may increase the analgesic activities of Morphine.
Zidovudine Injection Zidovudine Injection The metabolism of Selegiline can be decreased when combined with Zidovudine.
Altretamine Altretamine The risk or severity of adverse effects can be increased when Selegiline is combined with Amphetamine.
Cyclosporine Cyclosporine The metabolism of Cyclosporine can be decreased when combined with Selegiline.
Ondansetron Ondansetron The risk or severity of adverse effects can be increased when Ondansetron is combined with Selegiline.
Enoxaparin Injection Enoxaparin Injection The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Enoxaparin.
Granisetron Granisetron The risk or severity of adverse effects can be increased when Granisetron is combined with Selegiline.
Torsemide Torsemide Selegiline may increase the hypotensive activities of Torasemide.
Olanzapine Olanzapine The risk or severity of adverse effects can be increased when Olanzapine is combined with Selegiline.
Alosetron Alosetron The metabolism of Alosetron can be decreased when combined with Selegiline.
Entacapone Entacapone The risk or severity of adverse effects can be increased when Entacapone is combined with Selegiline.
Eprosartan Eprosartan Selegiline may increase the hypotensive activities of Eprosartan.
Hydroxychloroquine Hydroxychloroquine The metabolism of Selegiline can be decreased when combined with Hydroxychloroquine.
Meloxicam Meloxicam The metabolism of Selegiline can be decreased when combined with Meloxicam.
Oxcarbazepine Oxcarbazepine Oxcarbazepine may increase the serotonergic activities of Selegiline.
Telmisartan Telmisartan Selegiline may increase the hypotensive activities of Telmisartan.
Zaleplon Zaleplon The risk or severity of adverse effects can be increased when Zaleplon is combined with Selegiline.
Anakinra Anakinra The metabolism of Selegiline can be increased when combined with Anakinra.
Desloratadine Desloratadine The risk or severity of adverse effects can be increased when Desloratadine is combined with Selegiline.
Linezolid Linezolid The risk or severity of serotonin syndrome can be increased when Selegiline is combined with Linezolid.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Pentosan polysulfate.
Trimipramine Trimipramine The metabolism of Selegiline can be decreased when combined with Trimipramine.
Etanercept Injection Etanercept Injection The metabolism of Selegiline can be increased when combined with Etanercept.
Glycopyrrolate Glycopyrrolate Selegiline may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
Modafinil Modafinil The metabolism of Selegiline can be increased when combined with Modafinil.
Perindopril Perindopril Selegiline may increase the hypotensive activities of Perindopril.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate The risk or severity of hypertension can be increased when Selegiline is combined with Choline magnesium trisalicylate.
Dutasteride Dutasteride The risk or severity of hypertension can be increased when Selegiline is combined with Dutasteride.
Epinephrine Injection Epinephrine Injection Selegiline may increase the hypertensive activities of Epinephrine.
Eplerenone Eplerenone Selegiline may increase the hypotensive activities of Eplerenone.
Escitalopram Escitalopram The risk or severity of serotonin syndrome can be increased when Selegiline is combined with Escitalopram.
Olmesartan Olmesartan Selegiline may increase the hypotensive activities of Olmesartan.
Zonisamide Zonisamide The risk or severity of adverse effects can be increased when Zonisamide is combined with Selegiline.
Adalimumab Injection Adalimumab Injection The metabolism of Selegiline can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The risk or severity of serotonin syndrome can be increased when Selegiline is combined with Aripiprazole.
Atomoxetine Atomoxetine The risk or severity of adverse effects can be increased when Selegiline is combined with Atomoxetine.
Dexmethylphenidate Dexmethylphenidate Selegiline may increase the hypertensive activities of Dexmethylphenidate.
Atazanavir Atazanavir The metabolism of Selegiline can be decreased when combined with Atazanavir.
Almotriptan Almotriptan The metabolism of Almotriptan can be decreased when combined with Selegiline.
Eletriptan Eletriptan The risk or severity of adverse effects can be increased when Eletriptan is combined with Selegiline.
Mefloquine Mefloquine The metabolism of Selegiline can be decreased when combined with Mefloquine.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Selegiline.
Vardenafil Vardenafil The risk or severity of hypotension can be increased when Vardenafil is combined with Selegiline.
Aprepitant Aprepitant The metabolism of Selegiline can be decreased when combined with Aprepitant.
Interferon Beta-1a Subcutaneous Injection Interferon Beta-1a Subcutaneous Injection The metabolism of Selegiline can be decreased when combined with Interferon beta-1a.
Memantine Memantine The metabolism of Selegiline can be decreased when combined with Memantine.
Tegaserod Tegaserod The metabolism of Selegiline can be decreased when combined with Tegaserod.
Tadalafil Tadalafil Selegiline may increase the hypotensive activities of Tadalafil.
Frovatriptan Frovatriptan The metabolism of Frovatriptan can be decreased when combined with Selegiline.
Gemifloxacin Gemifloxacin The metabolism of Selegiline can be decreased when combined with Gemifloxacin.
Progesterone Progesterone The metabolism of Selegiline can be decreased when combined with Progesterone.
Apomorphine Injection Apomorphine Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Selegiline.
Infliximab Injection Infliximab Injection The metabolism of Selegiline can be increased when combined with Infliximab.
Oxandrolone Oxandrolone The metabolism of Selegiline can be decreased when combined with Oxandrolone.
Protriptyline Protriptyline Protriptyline may increase the serotonergic activities of Selegiline.
Rifaximin Rifaximin The metabolism of Selegiline can be increased when combined with Rifaximin.
Duloxetine Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Selegiline is combined with Duloxetine.
Norethindrone Norethindrone The bioavailability of Selegiline can be increased when combined with Norethisterone.
Trospium Trospium Selegiline may increase the central nervous system depressant (CNS depressant) activities of Trospium.
Bosentan Bosentan Selegiline may increase the hypotensive activities of Bosentan.
Cinacalcet Cinacalcet The metabolism of Cinacalcet can be decreased when combined with Selegiline.
Erlotinib Erlotinib The metabolism of Selegiline can be decreased when combined with Erlotinib.
Eszopiclone Eszopiclone The risk or severity of CNS depression can be increased when Selegiline is combined with Eszopiclone.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection Selegiline may increase the hypoglycemic activities of Insulin aspart.
Solifenacin Solifenacin Selegiline may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.
Voriconazole Voriconazole The metabolism of Selegiline can be decreased when combined with Voriconazole.
Dextroamphetamine Dextroamphetamine The risk or severity of adverse effects can be increased when Selegiline is combined with Amphetamine.
Entecavir Entecavir The metabolism of Entecavir can be decreased when combined with Selegiline.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The metabolism of Selegiline can be decreased when combined with Peginterferon alfa-2a.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The serum concentration of Selegiline can be increased when it is combined with Peginterferon alfa-2b.
Pramlintide Injection Pramlintide Injection Selegiline may increase the hypoglycemic activities of Pramlintide.
Sodium Oxybate Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Selegiline.
Exenatide Injection Exenatide Injection Selegiline may increase the hypoglycemic activities of Exenatide.
Isocarboxazid Isocarboxazid The risk or severity of adverse effects can be increased when Selegiline is combined with Isocarboxazid.
Ramelteon Ramelteon The metabolism of Ramelteon can be decreased when combined with Selegiline.
Darifenacin Darifenacin The metabolism of Darifenacin can be decreased when combined with Selegiline.
Fentanyl Fentanyl The risk or severity of adverse effects can be increased when Selegiline is combined with Fentanyl.
Pregabalin Pregabalin The therapeutic efficacy of Selegiline can be increased when used in combination with Pregabalin.
Deferasirox Deferasirox The serum concentration of Selegiline can be increased when it is combined with Deferasirox.
Phenylephrine Phenylephrine Selegiline may increase the hypertensive activities of Phenylephrine.
Tipranavir Tipranavir The metabolism of Tipranavir can be decreased when combined with Selegiline.
Felbamate Felbamate The metabolism of Selegiline can be decreased when combined with Felbamate.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection Selegiline may increase the hypoglycemic activities of Insulin detemir.
Ranolazine Ranolazine The serum concentration of Ranolazine can be increased when it is combined with Selegiline.
Abatacept Injection Abatacept Injection The metabolism of Selegiline can be increased when combined with Abatacept.
Rasagiline Rasagiline The risk or severity of adverse effects can be increased when Selegiline is combined with Rasagiline.
Imatinib Imatinib The metabolism of Selegiline can be decreased when combined with Imatinib.
Sitagliptin Sitagliptin The metabolism of Sitagliptin can be decreased when combined with Selegiline.
Gefitinib Gefitinib The metabolism of Selegiline can be decreased when combined with Gefitinib.
Albuterol Albuterol The risk or severity of hypertension can be increased when Salbutamol is combined with Selegiline.
Paliperidone Paliperidone The risk or severity of adverse effects can be increased when Selegiline is combined with Paliperidone.
Bortezomib Bortezomib The metabolism of Bortezomib can be decreased when combined with Selegiline.
Clofarabine Injection Clofarabine Injection Selegiline may increase the orthostatic hypotensive activities of Clofarabine.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The metabolism of Selegiline can be increased when combined with Insulin glulisine.
Primaquine Primaquine The metabolism of Primaquine can be decreased when combined with Selegiline.
Aliskiren Aliskiren Selegiline may increase the hypotensive activities of Aliskiren.
Pemetrexed Injection Pemetrexed Injection The metabolism of Pemetrexed can be decreased when combined with Selegiline.
Dimenhydrinate Dimenhydrinate The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Selegiline.
Lisdexamfetamine Lisdexamfetamine The risk or severity of adverse effects can be increased when Selegiline is combined with Lisdexamfetamine.
Nabilone Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Selegiline.
Sorafenib Sorafenib The metabolism of Selegiline can be decreased when combined with Sorafenib.
Sunitinib Sunitinib Selegiline may increase the hypoglycemic activities of Sunitinib.
Dronabinol Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Selegiline.
Lapatinib Lapatinib The metabolism of Selegiline can be decreased when combined with Lapatinib.
Levocetirizine Levocetirizine The risk or severity of adverse effects can be increased when Selegiline is combined with Levocetirizine.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Selegiline.
Mexiletine Mexiletine The metabolism of Selegiline can be decreased when combined with Mexiletine.
Armodafinil Armodafinil The metabolism of Selegiline can be decreased when combined with Armodafinil.
Temsirolimus Temsirolimus The metabolism of Selegiline can be decreased when combined with Temsirolimus.
Nilotinib Nilotinib The metabolism of Selegiline can be decreased when combined with Nilotinib.
Bexarotene Bexarotene The metabolism of Selegiline can be decreased when combined with Bexarotene.
Desmopressin Desmopressin The risk or severity of hypertension can be increased when Desmopressin is combined with Selegiline.
OnabotulinumtoxinA Injection OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Selegiline.
RimabotulinumtoxinB Injection RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Selegiline.
Etravirine Etravirine The metabolism of Selegiline can be decreased when combined with Etravirine.
Arsenic Trioxide Injection Arsenic Trioxide Injection Selegiline may increase the orthostatic hypotensive activities of Arsenic trioxide.
Desvenlafaxine Desvenlafaxine Selegiline may increase the serotonergic activities of Desvenlafaxine.
Cevimeline Cevimeline The metabolism of Cevimeline can be decreased when combined with Selegiline.
Nebivolol Nebivolol Selegiline may increase the hypotensive activities of Nebivolol.
Tretinoin Tretinoin Selegiline may increase the orthostatic hypotensive activities of Tretinoin.
Bendamustine Injection Bendamustine Injection The metabolism of Bendamustine can be decreased when combined with Selegiline.
Pilocarpine Pilocarpine The metabolism of Selegiline can be decreased when combined with Pilocarpine.
Flecainide Flecainide The metabolism of Selegiline can be decreased when combined with Flecainide.
Certolizumab Injection Certolizumab Injection The metabolism of Selegiline can be increased when combined with Certolizumab pegol.
Irinotecan Injection Irinotecan Injection The metabolism of Selegiline can be decreased when combined with Irinotecan.
Praziquantel Praziquantel The metabolism of Praziquantel can be decreased when combined with Selegiline.
Rufinamide Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Selegiline.
Midazolam Midazolam The risk or severity of adverse effects can be increased when Midazolam is combined with Selegiline.
Naltrexone Injection Naltrexone Injection The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Selegiline.
Eltrombopag Eltrombopag The metabolism of Selegiline can be decreased when combined with Eltrombopag.
Milnacipran Milnacipran Selegiline may increase the serotonergic activities of Milnacipran.
Fesoterodine Fesoterodine Selegiline may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.
Betaxolol Betaxolol Selegiline may increase the hypotensive activities of Betaxolol.
Iloperidone Iloperidone The risk or severity of adverse effects can be increased when Selegiline is combined with Iloperidone.
Prasugrel Prasugrel The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Prasugrel.
Lacosamide Lacosamide The risk or severity of adverse effects can be increased when Selegiline is combined with Lacosamide.
Everolimus Everolimus The metabolism of Selegiline can be decreased when combined with Everolimus.
Dronedarone Dronedarone The metabolism of Dronedarone can be decreased when combined with Selegiline.
AbobotulinumtoxinA Injection AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Selegiline.
Palonosetron Injection Palonosetron Injection The risk or severity of adverse effects can be increased when Palonosetron is combined with Selegiline.
Saxagliptin Saxagliptin Selegiline may increase the hypoglycemic activities of Saxagliptin.
Romidepsin Injection Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Selegiline.
Tapentadol Tapentadol The risk or severity of adverse effects can be increased when Tapentadol is combined with Selegiline.
Golimumab Injection Golimumab Injection The metabolism of Selegiline can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Selegiline can be decreased when combined with Pazopanib.
Asenapine Asenapine The risk or severity of adverse effects can be increased when Selegiline is combined with Asenapine.
Vigabatrin Vigabatrin The risk or severity of adverse effects can be increased when Selegiline is combined with Vigabatrin.
Pitavastatin Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Selegiline.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Selegiline.
Levonorgestrel Levonorgestrel The bioavailability of Selegiline can be increased when combined with Levonorgestrel.
Oxymorphone Oxymorphone The risk or severity of adverse effects can be increased when Oxymorphone is combined with Selegiline.
Dabigatran Dabigatran The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Dabigatran.
Liraglutide Injection Liraglutide Injection Selegiline may increase the hypoglycemic activities of Liraglutide.
Tocilizumab Injection Tocilizumab Injection The metabolism of Selegiline can be increased when combined with Tocilizumab.
Dalfampridine Dalfampridine The risk or severity of seizure can be increased when Selegiline is combined with Dalfampridine.
Fingolimod Fingolimod The metabolism of Fingolimod can be decreased when combined with Selegiline.
IncobotulinumtoxinA Injection IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Selegiline.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Selegiline.
Lurasidone Lurasidone The risk or severity of adverse effects can be increased when Selegiline is combined with Lurasidone.
Acetaminophen Injection Acetaminophen Injection Selegiline may increase the hepatotoxic activities of Acetaminophen.
Vilazodone Vilazodone The metabolism of Vilazodone can be decreased when combined with Selegiline.
Denileukin Diftitox Injection Denileukin Diftitox Injection Selegiline may increase the orthostatic hypotensive activities of Aldesleukin.
Terbutaline Injection Terbutaline Injection The risk or severity of adverse effects can be increased when Selegiline is combined with Terbutaline.
Azilsartan Azilsartan Selegiline may increase the orthostatic hypotensive activities of Azilsartan medoxomil.
Linagliptin Linagliptin Selegiline may increase the hypoglycemic activities of Linagliptin.
Rilpivirine Rilpivirine The metabolism of Selegiline can be decreased when combined with Rilpivirine.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Selegiline can be decreased when combined with Cyclophosphamide.
Abiraterone Abiraterone The serum concentration of Selegiline can be increased when it is combined with Abiraterone.
Rivaroxaban Rivaroxaban The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Rivaroxaban.
Ticagrelor Ticagrelor The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Ticagrelor.
Clobazam Clobazam The metabolism of Selegiline can be decreased when combined with Clobazam.
Vemurafenib Vemurafenib The serum concentration of Selegiline can be increased when it is combined with Vemurafenib.
Vismodegib Vismodegib The metabolism of Selegiline can be decreased when combined with Vismodegib.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Selegiline.
Cabergoline Cabergoline The metabolism of Cabergoline can be decreased when combined with Selegiline.
Ambrisentan Ambrisentan Selegiline may increase the hypotensive activities of Ambrisentan.
Fondaparinux Injection Fondaparinux Injection The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Fondaparinux.
Ezogabine Ezogabine The risk or severity of adverse effects can be increased when Tiagabine is combined with Selegiline.
Iloprost Iloprost Selegiline may increase the orthostatic hypotensive activities of Iloprost.
Enzalutamide Enzalutamide The metabolism of Selegiline can be decreased when combined with Enzalutamide.
Mirabegron Mirabegron The metabolism of Mirabegron can be decreased when combined with Selegiline.
Regorafenib Regorafenib The metabolism of Selegiline can be decreased when combined with Regorafenib.
Bosutinib Bosutinib The metabolism of Selegiline can be decreased when combined with Bosutinib.
Teriflunomide Teriflunomide The serum concentration of Selegiline can be decreased when it is combined with Teriflunomide.
Lorcaserin Lorcaserin Selegiline may increase the hypoglycemic activities of Mecasermin.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Selegiline.
Icosapent Ethyl Icosapent Ethyl The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Icosapent ethyl.
Alogliptin Alogliptin The metabolism of Alogliptin can be decreased when combined with Selegiline.
Ponatinib Ponatinib The metabolism of Selegiline can be decreased when combined with Ponatinib.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Selegiline.
Apixaban Apixaban The metabolism of Apixaban can be decreased when combined with Selegiline.
Canagliflozin Canagliflozin Selegiline may increase the orthostatic hypotensive activities of Canagliflozin.
Methazolamide Methazolamide Selegiline may increase the orthostatic hypotensive activities of Methazolamide.
Dabrafenib Dabrafenib The metabolism of Selegiline can be decreased when combined with Dabrafenib.
Ospemifene Ospemifene The metabolism of Ospemifene can be decreased when combined with Selegiline.
Trametinib Trametinib The metabolism of Selegiline can be decreased when combined with Trametinib.
Levomilnacipran Levomilnacipran Selegiline may increase the serotonergic activities of Levomilnacipran.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Selegiline.
Perampanel Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Selegiline.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Selegiline.
Avanafil Avanafil The risk or severity of hypotension can be increased when Avanafil is combined with Selegiline.
Ketorolac Injection Ketorolac Injection The metabolism of Selegiline can be decreased when combined with Ketorolac.
Obinutuzumab Injection Obinutuzumab Injection Selegiline may increase the orthostatic hypotensive activities of Obinutuzumab.
Simeprevir Simeprevir The metabolism of Selegiline can be decreased when combined with Simeprevir.
Dapagliflozin Dapagliflozin Selegiline may increase the orthostatic hypotensive activities of Dapagliflozin.
Apremilast Apremilast The metabolism of Selegiline can be increased when combined with Apremilast.
Droxidopa Droxidopa Selegiline may increase the hypertensive activities of Droxidopa.
Ceritinib Ceritinib The metabolism of Selegiline can be decreased when combined with Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Selegiline can be increased when combined with Siltuximab.
Albiglutide Injection Albiglutide Injection Selegiline may increase the hypoglycemic activities of Albiglutide.
Eslicarbazepine Eslicarbazepine The risk or severity of adverse effects can be increased when Selegiline is combined with Eslicarbazepine.
Belinostat Injection Belinostat Injection The metabolism of Selegiline can be increased when combined with Belinostat.
Testosterone Injection Testosterone Injection The metabolism of Selegiline can be decreased when combined with Testosterone.
Oritavancin Injection Oritavancin Injection The metabolism of Selegiline can be decreased when combined with Oritavancin.
Empagliflozin Empagliflozin Selegiline may increase the orthostatic hypotensive activities of Empagliflozin.
Vorapaxar Vorapaxar The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Vorapaxar.
Hydrocodone Hydrocodone Selegiline may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Hydrocodone.
Suvorexant Suvorexant Selegiline may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Dulaglutide Injection Dulaglutide Injection Selegiline may increase the hypoglycemic activities of Dulaglutide.
Edoxaban Edoxaban The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Edoxaban.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The metabolism of Selegiline can be decreased when combined with Peginterferon beta-1a.
Olaparib Olaparib The metabolism of Selegiline can be increased when combined with Olaparib.
Methamphetamine Methamphetamine The risk or severity of adverse effects can be increased when Selegiline is combined with Metamfetamine.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Selegiline.
Riociguat Riociguat Selegiline may increase the hypotensive activities of Riociguat.
Pirfenidone Pirfenidone The metabolism of Pirfenidone can be decreased when combined with Selegiline.
Secukinumab Injection Secukinumab Injection The metabolism of Selegiline can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection Selegiline may increase the hypotensive activities of Risperidone.
Insulin Human Inhalation Insulin Human Inhalation The metabolism of Selegiline can be increased when combined with Insulin human.
Lenvatinib Lenvatinib The metabolism of Selegiline can be decreased when combined with Lenvatinib.
Naloxegol Naloxegol The metabolism of Selegiline can be decreased when combined with Naloxegol.
Panobinostat Panobinostat The metabolism of Panobinostat can be decreased when combined with Selegiline.
Dinutuximab Injection Dinutuximab Injection Selegiline may increase the orthostatic hypotensive activities of Dinutuximab.
Haloperidol Injection Haloperidol Injection The risk or severity of CNS depression can be increased when Haloperidol is combined with Selegiline.
Amiloride Amiloride Selegiline may increase the orthostatic hypotensive activities of Amiloride.
Macitentan Macitentan Selegiline may increase the hypotensive activities of Macitentan.
Flibanserin Flibanserin The metabolism of Flibanserin can be decreased when combined with Selegiline.
Rolapitant Rolapitant The metabolism of Rolapitant can be decreased when combined with Selegiline.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Selegiline.
Ziprasidone Injection Ziprasidone Injection The risk or severity of adverse effects can be increased when Ziprasidone is combined with Selegiline.
Cariprazine Cariprazine The metabolism of Cariprazine can be decreased when combined with Selegiline.
Eluxadoline Eluxadoline The risk or severity of serotonin syndrome can be increased when Selegiline is combined with Eluxadoline.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The metabolism of Selegiline can be increased when combined with Insulin degludec.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Selegiline.
Osimertinib Osimertinib The serum concentration of Selegiline can be decreased when it is combined with Osimertinib.
Rifapentine Rifapentine The metabolism of Selegiline can be increased when combined with Rifapentine.
Lesinurad Lesinurad The metabolism of Lesinurad can be decreased when combined with Selegiline.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Selegiline may increase the orthostatic hypotensive activities of Amphotericin B.
Dexamethasone Injection Dexamethasone Injection The metabolism of Selegiline can be increased when combined with Dexamethasone.
Defibrotide Injection Defibrotide Injection The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Defibrotide.
Brivaracetam Injection Brivaracetam Injection The metabolism of Brivaracetam can be decreased when combined with Selegiline.
Cobicistat Cobicistat The metabolism of Selegiline can be decreased when combined with Cobicistat.
Midodrine Midodrine Selegiline may increase the hypertensive activities of Midodrine.
Selexipag Selexipag Selegiline may increase the hypotensive activities of Selexipag.
Pimavanserin Pimavanserin The risk or severity of adverse effects can be increased when Selegiline is combined with Pimavanserin.
Obeticholic Acid Obeticholic Acid The metabolism of Selegiline can be decreased when combined with Obeticholic acid.
Diphenhydramine Injection Diphenhydramine Injection The risk or severity of adverse effects can be increased when Selegiline is combined with Diphenhydramine.
Furosemide Injection Furosemide Injection Selegiline may increase the orthostatic hypotensive activities of Furosemide.
Rucaparib Rucaparib The metabolism of Rucaparib can be decreased when combined with Selegiline.
Lixisenatide Injection Lixisenatide Injection Selegiline may increase the hypoglycemic activities of Lixisenatide.
Brigatinib Brigatinib The metabolism of Brigatinib can be decreased when combined with Selegiline.
Doxepin (Insomnia) Doxepin (Insomnia) Selegiline may increase the serotonergic activities of Doxepin.
Deutetrabenazine Deutetrabenazine The risk or severity of adverse effects can be increased when Selegiline is combined with Deutetrabenazine.
Valbenazine Valbenazine The metabolism of Valbenazine can be decreased when combined with Selegiline.
Safinamide Safinamide The risk or severity of adverse effects can be increased when Selegiline is combined with Safinamide.
Midostaurin Midostaurin The metabolism of Selegiline can be decreased when combined with Midostaurin.
Enasidenib Enasidenib The metabolism of Selegiline can be decreased when combined with Enasidenib.
Delafloxacin Delafloxacin The metabolism of Selegiline can be increased when combined with Delafloxacin.
Betrixaban Betrixaban The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Betrixaban.
Letermovir Letermovir The metabolism of Selegiline can be decreased when combined with Letermovir.
Semaglutide Injection Semaglutide Injection Selegiline may increase the hypoglycemic activities of Semaglutide.
Tetrabenazine Tetrabenazine The risk or severity of adverse effects can be increased when Selegiline is combined with Tetrabenazine.
Ertugliflozin Ertugliflozin Selegiline may increase the hypoglycemic activities of Ertugliflozin.
Buprenorphine Injection Buprenorphine Injection The risk or severity of serotonin syndrome and opioid toxicity can be increased when Buprenorphine is combined with Selegiline.
Apalutamide Apalutamide The metabolism of Selegiline can be decreased when combined with Apalutamide.
Fostamatinib Fostamatinib The risk or severity of hypotension can be increased when Fostamatinib is combined with Selegiline.
Avatrombopag Avatrombopag The metabolism of Selegiline can be increased when combined with Avatrombopag.
Lofexidine Lofexidine The therapeutic efficacy of Selegiline can be increased when used in combination with Lofexidine.
Eliglustat Eliglustat The metabolism of Selegiline can be decreased when combined with Eliglustat.
Encorafenib Encorafenib The metabolism of Encorafenib can be decreased when combined with Selegiline.
Binimetinib Binimetinib The metabolism of Binimetinib can be decreased when combined with Selegiline.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Selegiline.
Eravacycline Injection Eravacycline Injection The metabolism of Eravacycline can be decreased when combined with Selegiline.
Tafenoquine Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Selegiline.
Cannabidiol Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Selegiline.
Dacomitinib Dacomitinib The metabolism of Dacomitinib can be decreased when combined with Selegiline.
Stiripentol Stiripentol The metabolism of Selegiline can be decreased when combined with Stiripentol.
Gilteritinib Gilteritinib The therapeutic efficacy of Selegiline can be decreased when used in combination with Gilteritinib.
Glasdegib Glasdegib The metabolism of Glasdegib can be decreased when combined with Selegiline.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Selegiline.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Selegiline.
Rifamycin Rifamycin The metabolism of Selegiline can be decreased when combined with Rifamycin.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Selegiline can be increased when combined with Emapalumab.
Siponimod Siponimod The metabolism of Siponimod can be decreased when combined with Selegiline.
Acyclovir Ophthalmic Acyclovir Ophthalmic The metabolism of Acyclovir can be decreased when combined with Selegiline.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Caplacizumab.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Selegiline.
Alpelisib Alpelisib The serum concentration of Selegiline can be decreased when it is combined with Alpelisib.
Brexanolone Injection Brexanolone Injection The risk or severity of adverse effects can be increased when Selegiline is combined with Brexanolone.
Solriamfetol Solriamfetol The risk or severity of hypertension can be increased when Solriamfetol is combined with Selegiline.
Triclabendazole Triclabendazole The metabolism of Selegiline can be decreased when combined with Triclabendazole.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Selegiline.
Pitolisant Pitolisant The serum concentration of Selegiline can be decreased when it is combined with Pitolisant.
Fedratinib Fedratinib The metabolism of Selegiline can be decreased when combined with Fedratinib.
Phenytoin Injection Phenytoin Injection The metabolism of Selegiline can be decreased when combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Selegiline can be decreased when combined with Fosphenytoin.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Selegiline.
Voxelotor Voxelotor The metabolism of Voxelotor can be decreased when combined with Selegiline.
Avapritinib Avapritinib The metabolism of Avapritinib can be decreased when combined with Selegiline.
Lumateperone Lumateperone The therapeutic efficacy of Selegiline can be decreased when used in combination with Lumateperone.
Lasmiditan Lasmiditan The risk or severity of serotonin syndrome can be increased when Selegiline is combined with Lasmiditan.
Cenobamate Cenobamate The serum concentration of Cenobamate can be decreased when it is combined with Selegiline.
Ozanimod Ozanimod The metabolism of Ozanimod can be decreased when combined with Selegiline.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Selegiline.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Selegiline.
Selpercatinib Selpercatinib The serum concentration of Selpercatinib can be increased when it is combined with Selegiline.
Capmatinib Capmatinib The metabolism of Selegiline can be decreased when combined with Capmatinib.
Lemborexant Lemborexant The serum concentration of Selegiline can be decreased when it is combined with Lemborexant.
Fenfluramine Fenfluramine The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Selegiline.
Pralsetinib Pralsetinib The metabolism of Selegiline can be decreased when combined with Pralsetinib.
Opicapone Opicapone The metabolism of Selegiline can be decreased when combined with Opicapone.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Selegiline can be decreased when it is combined with Satralizumab.
Naxitamab-gqgk Injection Naxitamab-gqgk Injection The risk or severity of hypertension can be increased when Selegiline is combined with Naxitamab.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The bioavailability of Selegiline can be increased when combined with Drospirenone.
Viloxazine Viloxazine The risk or severity of adverse effects can be increased when Selegiline is combined with Viloxazine.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Selegiline.
Fenoprofen Fenoprofen The risk or severity of hypertension can be increased when Fenoprofen is combined with Selegiline.
Indomethacin Indomethacin The metabolism of Selegiline can be decreased when combined with Indomethacin.
Mefenamic Acid Mefenamic Acid The metabolism of Selegiline can be decreased when combined with Mefenamic acid.
Naproxen Naproxen The metabolism of Selegiline can be decreased when combined with Naproxen.
Tolmetin Tolmetin The risk or severity of hypertension can be increased when Tolmetin is combined with Selegiline.
Sulindac Sulindac The risk or severity of hypertension can be increased when Sulindac is combined with Selegiline.
Trazodone Trazodone Selegiline may increase the serotonergic activities of Trazodone.
Hydroxyurea Hydroxyurea The metabolism of Selegiline can be decreased when combined with Hydroxyurea.
Floxuridine Floxuridine The metabolism of Selegiline can be decreased when combined with Floxuridine.
Phenobarbital Phenobarbital The metabolism of Phenobarbital can be decreased when combined with Selegiline.
Metaxalone Metaxalone The risk or severity of adverse effects can be increased when Metaxalone is combined with Selegiline.
Levorphanol Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Selegiline.
Primidone Primidone The metabolism of Selegiline can be increased when combined with Primidone.
Methsuximide Methsuximide The risk or severity of adverse effects can be increased when Selegiline is combined with Methsuximide.
Diethylpropion Diethylpropion The risk or severity of adverse effects can be increased when Selegiline is combined with Diethylpropion.
Chlorpromazine Chlorpromazine The metabolism of Selegiline can be decreased when combined with Chlorpromazine.
Diazepam Diazepam The risk or severity of adverse effects can be increased when Diazepam is combined with Selegiline.
Oxazepam Oxazepam The risk or severity of adverse effects can be increased when Oxazepam is combined with Selegiline.
Flurazepam Flurazepam The risk or severity of adverse effects can be increased when Flurazepam is combined with Selegiline.
Clorazepate Clorazepate The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Selegiline.
Lorazepam Lorazepam The risk or severity of adverse effects can be increased when Lorazepam is combined with Selegiline.
Phenoxybenzamine Phenoxybenzamine Selegiline may increase the hypotensive activities of Phenoxybenzamine.
Carmustine Carmustine The metabolism of Carmustine can be decreased when combined with Selegiline.
Amantadine Amantadine The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Selegiline.
Codeine Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Selegiline.
Meprobamate Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Selegiline.
Chlordiazepoxide Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Selegiline.
Bromocriptine Bromocriptine Selegiline may increase the hypertensive activities of Bromocriptine.
Metaproterenol Metaproterenol The risk or severity of adverse effects can be increased when Selegiline is combined with Orciprenaline.
Tranylcypromine Tranylcypromine The metabolism of Selegiline can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine The risk or severity of adverse effects can be increased when Phenelzine is combined with Selegiline.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Selegiline is combined with Procarbazine.
Ergoloid Mesylates Ergoloid Mesylates The risk or severity of adverse effects can be increased when Selegiline is combined with Ergoloid mesylate.
Minocycline Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Selegiline.
Prochlorperazine Prochlorperazine The therapeutic efficacy of Selegiline can be decreased when used in combination with Prochlorperazine.
Thioridazine Thioridazine The therapeutic efficacy of Selegiline can be decreased when used in combination with Thioridazine.
Trifluoperazine Trifluoperazine The therapeutic efficacy of Selegiline can be decreased when used in combination with Trifluoperazine.
Dapsone Dapsone The metabolism of Selegiline can be decreased when combined with Dapsone.
Sulfadiazine Sulfadiazine The metabolism of Selegiline can be decreased when combined with Sulfadiazine.
Oxycodone Oxycodone Selegiline may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Oxycodone.
Methadone Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Selegiline.
Oxybutynin Oxybutynin The metabolism of Selegiline can be decreased when combined with Oxybutynin.
Benztropine Benztropine Selegiline may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
Maprotiline Maprotiline The risk or severity of adverse effects can be increased when Maprotiline is combined with Selegiline.
Ibuprofen Ibuprofen The metabolism of Ibuprofen can be decreased when combined with Selegiline.
Trihexyphenidyl Trihexyphenidyl Selegiline may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.
Orphenadrine Orphenadrine Selegiline may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Perphenazine Perphenazine The therapeutic efficacy of Selegiline can be decreased when used in combination with Perphenazine.
Azathioprine Azathioprine The metabolism of Azathioprine can be decreased when combined with Selegiline.
Fluphenazine Fluphenazine The therapeutic efficacy of Selegiline can be decreased when used in combination with Fluphenazine.
Phentermine Phentermine The risk or severity of adverse effects can be increased when Selegiline is combined with Phentermine.
Methylphenidate Methylphenidate Selegiline may increase the hypertensive activities of Methylphenidate.
Amoxapine Amoxapine The metabolism of Amoxapine can be decreased when combined with Selegiline.
Sulfasalazine Sulfasalazine The risk or severity of hypertension can be increased when Sulfasalazine is combined with Selegiline.
Hydrocortisone Hydrocortisone The metabolism of Selegiline can be increased when combined with Hydrocortisone.
Doxorubicin Doxorubicin The metabolism of Selegiline can be decreased when combined with Doxorubicin.
Carbamazepine Carbamazepine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Selegiline.
Molindone Molindone The therapeutic efficacy of Molindone can be decreased when used in combination with Selegiline.
Methyldopa Methyldopa Selegiline may decrease the hypotensive activities of Methyldopa.
Clonidine Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Selegiline.
Prazosin Prazosin Selegiline may increase the hypotensive activities of Prazosin.
Hydralazine Hydralazine Selegiline may increase the hypotensive activities of Hydralazine.
Cimetidine Cimetidine The metabolism of Cimetidine can be decreased when combined with Selegiline.
Warfarin Warfarin The metabolism of Selegiline can be decreased when combined with Warfarin.
Clonazepam Clonazepam The risk or severity of adverse effects can be increased when Selegiline is combined with Clonazepam.
Loperamide Loperamide The metabolism of Selegiline can be decreased when combined with Loperamide.
Promethazine Promethazine The risk or severity of extrapyramidal symptoms can be increased when Promethazine is combined with Selegiline.
Meclofenamate Meclofenamate The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Selegiline.
Griseofulvin Griseofulvin The metabolism of Selegiline can be increased when combined with Griseofulvin.
Loxapine Loxapine The therapeutic efficacy of Selegiline can be decreased when used in combination with Loxapine.
Chloroquine Chloroquine The metabolism of Chloroquine can be decreased when combined with Selegiline.
Quinine Quinine The metabolism of Quinine can be decreased when combined with Selegiline.
Ethosuximide Ethosuximide The risk or severity of adverse effects can be increased when Ethosuximide is combined with Selegiline.
Triamterene Triamterene Selegiline may increase the orthostatic hypotensive activities of Triamterene.
Sulfinpyrazone Sulfinpyrazone The metabolism of Selegiline can be decreased when combined with Sulfinpyrazone.
Chlorothiazide Chlorothiazide Selegiline may increase the hypotensive activities of Chlorothiazide.
Chlorthalidone Chlorthalidone Selegiline may increase the hypotensive activities of Chlorthalidone.
Metolazone Metolazone Selegiline may increase the hypotensive activities of Metolazone.
Secobarbital Secobarbital The metabolism of Selegiline can be increased when combined with Secobarbital.
Desipramine Desipramine The metabolism of Desipramine can be decreased when combined with Selegiline.
Amitriptyline Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Selegiline.
Imipramine Imipramine The metabolism of Selegiline can be decreased when combined with Imipramine.
Probenecid Probenecid The metabolism of Selegiline can be increased when combined with Probenecid.
Quinidine Quinidine The metabolism of Selegiline can be decreased when combined with Quinidine.
Procainamide Procainamide The metabolism of Procainamide can be decreased when combined with Selegiline.
Isoniazid Isoniazid The metabolism of Selegiline can be decreased when combined with Isoniazid.
Rifampin Rifampin The metabolism of Selegiline can be increased when combined with Rifampicin.
Disopyramide Disopyramide The metabolism of Disopyramide can be decreased when combined with Selegiline.
Valproic Acid Valproic Acid The risk or severity of adverse effects can be increased when Valproic acid is combined with Selegiline.
Tamoxifen Tamoxifen The metabolism of Selegiline can be decreased when combined with Tamoxifen.
Butabarbital Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Selegiline.
Levothyroxine Levothyroxine The metabolism of Selegiline can be decreased when combined with Levothyroxine.
Methimazole Methimazole The metabolism of Selegiline can be decreased when combined with Methimazole.
Chlorpropamide Chlorpropamide Selegiline may increase the hypoglycemic activities of Chlorpropamide.
Tolbutamide Tolbutamide The metabolism of Tolbutamide can be decreased when combined with Selegiline.
Tolazamide Tolazamide Selegiline may increase the hypoglycemic activities of Tolazamide.
Dextromethorphan Dextromethorphan The risk or severity of serotonin syndrome can be increased when Selegiline is combined with Dextromethorphan.
Cyclobenzaprine Cyclobenzaprine Cyclobenzaprine may increase the serotonergic activities of Selegiline.
Niacin Niacin The metabolism of Selegiline can be decreased when combined with Niacin.
Baclofen Baclofen The risk or severity of hypotension can be increased when Baclofen is combined with Selegiline.
Doxylamine Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Selegiline.
Cyproheptadine Cyproheptadine Selegiline may increase the anticholinergic activities of Cyproheptadine.
Clemastine Clemastine Selegiline may increase the anticholinergic activities of Clemastine.
Chlorpheniramine Chlorpheniramine The risk or severity of adverse effects can be increased when Selegiline is combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Selegiline.
Meclizine Meclizine The risk or severity of adverse effects can be increased when Meclizine is combined with Selegiline.
Methyclothiazide Methyclothiazide Selegiline may increase the orthostatic hypotensive activities of Methyclothiazide.
Hydrochlorothiazide Hydrochlorothiazide Selegiline may increase the hypotensive activities of Hydrochlorothiazide.
Dantrolene Dantrolene The risk or severity of adverse effects can be increased when Selegiline is combined with Dantrolene.
Chlorzoxazone Chlorzoxazone The metabolism of Chlorzoxazone can be decreased when combined with Selegiline.
Carisoprodol Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Selegiline.
Methocarbamol Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Selegiline.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) Selegiline may increase the hypotensive activities of Propranolol.
Minoxidil Minoxidil Selegiline may increase the hypotensive activities of Minoxidil.
Pseudoephedrine Pseudoephedrine The risk or severity of adverse effects can be increased when Selegiline is combined with Pseudoephedrine.
Nortriptyline Nortriptyline The metabolism of Nortriptyline can be decreased when combined with Selegiline.
Spironolactone Spironolactone Selegiline may increase the orthostatic hypotensive activities of Spironolactone.
Amphotericin B Injection Amphotericin B Injection Selegiline may increase the orthostatic hypotensive activities of Amphotericin B.
Nadolol Nadolol Selegiline may increase the hypotensive activities of Nadolol.
Butorphanol Injection Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Selegiline.
Nalbuphine Injection Nalbuphine Injection The risk or severity of adverse effects can be increased when Nalbuphine is combined with Selegiline.
Trimethobenzamide Trimethobenzamide The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Selegiline.
Flavoxate Flavoxate Selegiline may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
Papaverine Papaverine Selegiline may increase the orthostatic hypotensive activities of Papaverine.
Fluorouracil Injection Fluorouracil Injection The metabolism of Selegiline can be decreased when combined with Fluorouracil.
Colchicine Colchicine The metabolism of Selegiline can be decreased when combined with Colchicine.
Dacarbazine Dacarbazine The metabolism of Dacarbazine can be decreased when combined with Selegiline.
Acetazolamide Acetazolamide The risk or severity of adverse effects can be increased when Acetazolamide is combined with Selegiline.
Ketoconazole Ketoconazole The metabolism of Selegiline can be decreased when combined with Ketoconazole.
Pyrantel Pyrantel The risk or severity of adverse effects can be increased when Selegiline is combined with Pyrantel.
Thiotepa Injection Thiotepa Injection The metabolism of Selegiline can be decreased when combined with Thiotepa.
Captopril Captopril Selegiline may increase the hypotensive activities of Captopril.
Dipyridamole Dipyridamole Selegiline may increase the orthostatic hypotensive activities of Dipyridamole.
Isoxsuprine Isoxsuprine Selegiline may increase the orthostatic hypotensive activities of Isoxsuprine.
Vinblastine Vinblastine The metabolism of Selegiline can be decreased when combined with Vinblastine.
Ethacrynic Acid Ethacrynic Acid Selegiline may increase the orthostatic hypotensive activities of Etacrynic acid.
Metoprolol Metoprolol The metabolism of Metoprolol can be decreased when combined with Selegiline.
Hydroxyzine Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Selegiline.
Thiothixene Thiothixene The therapeutic efficacy of Thiothixene can be decreased when used in combination with Selegiline.
Aspirin Aspirin The risk or severity of bleeding and hemorrhage can be increased when Acetylsalicylic acid is combined with Selegiline.
Salsalate Salsalate The risk or severity of hypertension can be increased when Selegiline is combined with Salsalate.
Alprazolam Alprazolam The risk or severity of adverse effects can be increased when Alprazolam is combined with Selegiline.
Temazepam Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Selegiline.
Triazolam Triazolam The risk or severity of adverse effects can be increased when Triazolam is combined with Selegiline.
Dicyclomine Dicyclomine Selegiline may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Hyoscyamine Hyoscyamine Selegiline may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.
Propantheline Propantheline Selegiline may increase the central nervous system depressant (CNS depressant) activities of Propantheline.
Trimethoprim Trimethoprim The metabolism of Selegiline can be decreased when combined with Trimethoprim.
Diltiazem Diltiazem Selegiline may increase the hypotensive activities of Diltiazem.
Nifedipine Nifedipine Selegiline may increase the orthostatic hypotensive activities of Nifedipine.
Timolol Timolol The metabolism of Timolol can be decreased when combined with Selegiline.
Verapamil Verapamil Selegiline may increase the orthostatic hypotensive activities of Verapamil.
Atenolol Atenolol Selegiline may increase the hypotensive activities of Atenolol.
Pindolol Pindolol Selegiline may increase the hypotensive activities of Pindolol.
Cisplatin Injection Cisplatin Injection The metabolism of Selegiline can be decreased when combined with Cisplatin.
Diflunisal Diflunisal The risk or severity of hypertension can be increased when Diflunisal is combined with Selegiline.
Piroxicam Piroxicam The metabolism of Selegiline can be decreased when combined with Piroxicam.
Bumetanide Bumetanide Selegiline may increase the orthostatic hypotensive activities of Bumetanide.
Streptozocin Streptozocin The metabolism of Selegiline can be increased when combined with Streptozocin.
Etoposide Etoposide The metabolism of Etoposide can be decreased when combined with Selegiline.
Glyburide Glyburide The metabolism of Selegiline can be decreased when combined with Glyburide.
Glipizide Glipizide Selegiline may increase the hypoglycemic activities of Glipizide.
Indapamide Indapamide Selegiline may increase the hypotensive activities of Indapamide.
Nafcillin Injection Nafcillin Injection The metabolism of Selegiline can be increased when combined with Nafcillin.
Pentoxifylline Pentoxifylline The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Pentoxifylline.
Pentamidine Injection Pentamidine Injection The metabolism of Pentamidine can be decreased when combined with Selegiline.
Labetalol Labetalol Selegiline may increase the hypotensive activities of Labetalol.
Gemfibrozil Gemfibrozil The metabolism of Selegiline can be decreased when combined with Gemfibrozil.
Guanabenz Guanabenz Selegiline may increase the hypotensive activities of Guanabenz.
Ketoprofen Ketoprofen The metabolism of Selegiline can be decreased when combined with Ketoprofen.
Pimozide Pimozide The therapeutic efficacy of Pimozide can be decreased when used in combination with Selegiline.
Enalapril Enalapril Selegiline may increase the hypotensive activities of Enalapril.
Flurbiprofen Flurbiprofen The metabolism of Selegiline can be decreased when combined with Flurbiprofen.
Amiodarone Amiodarone The metabolism of Amiodarone can be decreased when combined with Selegiline.
Buspirone Buspirone The risk or severity of hypertension can be increased when Selegiline is combined with Buspirone.
Lovastatin Lovastatin The metabolism of Selegiline can be decreased when combined with Lovastatin.
Ciprofloxacin Ciprofloxacin The metabolism of Selegiline can be decreased when combined with Ciprofloxacin.
Mesalamine Mesalamine The risk or severity of hypertension can be increased when Mesalazine is combined with Selegiline.
Diclofenac Diclofenac The metabolism of Selegiline can be decreased when combined with Diclofenac.
Fluoxetine Fluoxetine The serum concentration of Selegiline can be increased when it is combined with Fluoxetine.
Nimodipine Nimodipine Selegiline may increase the hypotensive activities of Nimodipine.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The metabolism of Selegiline can be decreased when combined with Interferon alfa-2b.
Clozapine Clozapine The metabolism of Selegiline can be decreased when combined with Clozapine.
Estazolam Estazolam The risk or severity of adverse effects can be increased when Selegiline is combined with Estazolam.
Idarubicin Idarubicin The metabolism of Idarubicin can be decreased when combined with Selegiline.
Ofloxacin Ofloxacin The metabolism of Selegiline can be decreased when combined with Ofloxacin.
Benazepril Benazepril Selegiline may increase the hypotensive activities of Benazepril.
Etodolac Etodolac The metabolism of Selegiline can be decreased when combined with Etodolac.
Felodipine Felodipine The metabolism of Selegiline can be decreased when combined with Felodipine.
Fosinopril Fosinopril Selegiline may increase the hypotensive activities of Fosinopril.
Nabumetone Nabumetone The metabolism of Nabumetone can be decreased when combined with Selegiline.
Quinapril Quinapril Selegiline may increase the hypotensive activities of Quinapril.
Ramipril Ramipril Selegiline may increase the hypotensive activities of Ramipril.
Simvastatin Simvastatin The metabolism of Simvastatin can be decreased when combined with Selegiline.
Amlodipine Amlodipine Selegiline may increase the hypotensive activities of Amlodipine.
Teniposide Injection Teniposide Injection The metabolism of Selegiline can be decreased when combined with Teniposide.
Itraconazole Itraconazole The metabolism of Itraconazole can be decreased when combined with Selegiline.
Lisinopril Lisinopril Selegiline may increase the hypotensive activities of Lisinopril.
Oxaprozin Oxaprozin The risk or severity of hypertension can be increased when Oxaprozin is combined with Selegiline.
Atovaquone Atovaquone The metabolism of Selegiline can be decreased when combined with Atovaquone.
Rifabutin Rifabutin The metabolism of Selegiline can be increased when combined with Rifabutin.
Sotalol Sotalol The metabolism of Sotalol can be decreased when combined with Selegiline.
Bisoprolol Bisoprolol Selegiline may increase the hypotensive activities of Bisoprolol.
Zolpidem Zolpidem Selegiline may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Doxazosin Doxazosin Selegiline may increase the hypotensive activities of Doxazosin.
Terazosin Terazosin Selegiline may increase the hypotensive activities of Terazosin.
Isradipine Isradipine Selegiline may increase the hypotensive activities of Isradipine.
Omeprazole Omeprazole The metabolism of Selegiline can be decreased when combined with Omeprazole.
Cisapride Cisapride The metabolism of Cisapride can be decreased when combined with Selegiline.
Gabapentin Gabapentin The risk or severity of adverse effects can be increased when Gabapentin is combined with Selegiline.
Fluvastatin Fluvastatin The metabolism of Selegiline can be decreased when combined with Fluvastatin.
Venlafaxine Venlafaxine The metabolism of Selegiline can be decreased when combined with Venlafaxine.
Fluvoxamine Fluvoxamine Fluvoxamine may increase the serotonergic activities of Selegiline.
Nefazodone Nefazodone Selegiline may increase the serotonergic activities of Nefazodone.
Lamotrigine Lamotrigine The risk or severity of adverse effects can be increased when Lamotrigine is combined with Selegiline.
Losartan Losartan Selegiline may increase the hypotensive activities of Losartan.
Tramadol Tramadol The risk or severity of serotonin syndrome and seizure can be increased when Selegiline is combined with Tramadol.
Vinorelbine Injection Vinorelbine Injection The metabolism of Selegiline can be decreased when combined with Vinorelbine.
Moexipril Moexipril Selegiline may increase the hypotensive activities of Moexipril.
Lansoprazole Lansoprazole The metabolism of Selegiline can be decreased when combined with Lansoprazole.
Ifosfamide Injection Ifosfamide Injection The metabolism of Selegiline can be decreased when combined with Ifosfamide.
Nicardipine Nicardipine The metabolism of Selegiline can be decreased when combined with Nicardipine.
Bupropion Bupropion The risk or severity of adverse effects can be increased when Selegiline is combined with Bupropion.
Ticlopidine Ticlopidine The metabolism of Selegiline can be decreased when combined with Ticlopidine.
Saquinavir Saquinavir The metabolism of Selegiline can be decreased when combined with Saquinavir.
Metformin Metformin Selegiline may increase the hypoglycemic activities of Metformin.
Dalteparin Injection Dalteparin Injection The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Dalteparin.
Nisoldipine Nisoldipine Selegiline may increase the hypotensive activities of Nisoldipine.
Riluzole Riluzole The metabolism of Riluzole can be decreased when combined with Selegiline.
Amifostine Injection Amifostine Injection Selegiline may increase the orthostatic hypotensive activities of Amifostine.
Acarbose Acarbose Selegiline may increase the hypoglycemic activities of Acarbose.
Glimepiride Glimepiride Selegiline may increase the hypoglycemic activities of Glimepiride.
Anastrozole Anastrozole The metabolism of Selegiline can be decreased when combined with Anastrozole.
Ritonavir Ritonavir The serum concentration of Selegiline can be increased when it is combined with Ritonavir.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Selegiline.
Zafirlukast Zafirlukast The metabolism of Selegiline can be decreased when combined with Zafirlukast.
Mirtazapine Mirtazapine Selegiline may increase the serotonergic activities of Mirtazapine.
Trandolapril Trandolapril Selegiline may increase the hypotensive activities of Trandolapril.
Topiramate Topiramate The risk or severity of adverse effects can be increased when Topiramate is combined with Selegiline.
Zileuton Zileuton The metabolism of Zileuton can be decreased when combined with Selegiline.
Valsartan Valsartan Selegiline may increase the hypotensive activities of Valsartan.
Insulin Lispro Injection Insulin Lispro Injection The metabolism of Selegiline can be increased when combined with Insulin lispro.
Pramipexole Pramipexole Selegiline may increase the sedative activities of Pramipexole.
Donepezil Donepezil The risk or severity of adverse effects can be increased when Donepezil is combined with Selegiline.
Nelfinavir Nelfinavir The metabolism of Selegiline can be decreased when combined with Nelfinavir.
Azithromycin Azithromycin The metabolism of Selegiline can be decreased when combined with Azithromycin.
Loratadine Loratadine The metabolism of Selegiline can be decreased when combined with Loratadine.
Carvedilol Carvedilol Selegiline may increase the hypotensive activities of Carvedilol.
Nilutamide Nilutamide The metabolism of Selegiline can be decreased when combined with Nilutamide.
Flutamide Flutamide The metabolism of Flutamide can be decreased when combined with Selegiline.
Bicalutamide Bicalutamide The metabolism of Selegiline can be decreased when combined with Bicalutamide.
Sertraline Sertraline The risk or severity of serotonin syndrome can be increased when Selegiline is combined with Sertraline.
Propafenone Propafenone The metabolism of Selegiline can be decreased when combined with Propafenone.
Letrozole Letrozole The metabolism of Selegiline can be decreased when combined with Letrozole.
Raloxifene Raloxifene The metabolism of Selegiline can be decreased when combined with Raloxifene.
Irbesartan Irbesartan Selegiline may increase the hypotensive activities of Irbesartan.
Tamsulosin Tamsulosin Selegiline may increase the orthostatic hypotensive activities of Tamsulosin.
Ropinirole Ropinirole The risk or severity of adverse effects can be increased when Selegiline is combined with Ropinirole.
Finasteride Finasteride The risk or severity of hypertension can be increased when Selegiline is combined with Finasteride.
Quetiapine Quetiapine The risk or severity of adverse effects can be increased when Selegiline is combined with Quetiapine.
Cetirizine Cetirizine The risk or severity of adverse effects can be increased when Cetirizine is combined with Selegiline.
Paroxetine Paroxetine Paroxetine may increase the serotonergic activities of Selegiline.
Tolcapone Tolcapone Selegiline may increase the orthostatic hypotensive activities of Tolcapone.
Citalopram Citalopram The risk or severity of serotonin syndrome can be increased when Selegiline is combined with Citalopram.
Capecitabine Capecitabine The metabolism of Selegiline can be decreased when combined with Capecitabine.
Efavirenz Efavirenz The metabolism of Selegiline can be decreased when combined with Efavirenz.
Sildenafil Sildenafil The metabolism of Selegiline can be decreased when combined with Sildenafil.
Pioglitazone Pioglitazone The metabolism of Selegiline can be decreased when combined with Pioglitazone.
Celecoxib Celecoxib The metabolism of Celecoxib can be decreased when combined with Selegiline.
Rosiglitazone Rosiglitazone The metabolism of Selegiline can be decreased when combined with Rosiglitazone.
Tolterodine Tolterodine Selegiline may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.
Thalidomide Thalidomide Selegiline may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Balsalazide Balsalazide The risk or severity of hypertension can be increased when Balsalazide is combined with Selegiline.
Nateglinide Nateglinide The metabolism of Selegiline can be decreased when combined with Nateglinide.
Galantamine Galantamine The metabolism of Galantamine can be decreased when combined with Selegiline.
Levetiracetam Levetiracetam The risk or severity of adverse effects can be increased when Selegiline is combined with Levetiracetam.
Rabeprazole Rabeprazole The metabolism of Selegiline can be decreased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Selegiline can be decreased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists